Sean Cahill, Director of Health Policy Research at the Fenway Institute, gives us a look at the National HIV/AIDS Strategy.
amfAR, The Foundation for AIDS Research, announced that three research teams have been awarded $2 million each to pursue a range of strategies aimed at curing HIV.
U.S. health officials have updated their strategic plan for fighting AIDS, setting new goals for reducing infections and deaths.
CEL-SCI Corporation announced it has added a second clinical site for its Phase I clinical trial evaluating peri-anal wart immunotherapy in HIV/HPV co-infected men and women with its investigational cancer immunotherapy Multikine.
amfAR announced the beta launch of its PEPFAR Country/Regional Operational Plan database, a comprehensive, navigable database of PEPFAR's planned funding of HIV/AIDS activities from 2007 to 2014.
The 2015 International AIDS Society conference will be remembered as a milestone in the global effort to eliminate new infections and expand treatment to everyone living with HIV worldwide, experts said this week in Vancouver.
In an effort to keep the memory of brilliant journalist Jeff Schmalz alive, Samuel G. Freedman and Kerry Donahue have created a Kickstarter campaign to raise funds for "Dying Words."
A clinical study by the NIH shows that adherence to PrEP was high among young, single black women in South Africa, as well as MSM and TGW in New York and Thailand.
Created by openly gay HIV+ writer/performer Charles Sanchez, "Merce" was inspired by the rich lives and bright spirits of people living with HIV today.
CytoDyn believes that complete virologic suppression through treatment with a single agent, rather than through the widely used HAART combination therapy, could present a significant opportunity to treat HIV infection.